Skip to content

MAZE MAZE Operating Cash Flow

Operating Cash Flow at other companies

Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$1.43B+74.4%
Septerna, Inc. logo
Septerna, Inc.SEPN
-$25.63M-9.8%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
-$60.58M-146%
Olema Pharmaceuticals, Inc. logo
Olema Pharmaceuticals, Inc.OLMA
-$45.99M-4.6%
Zymeworks logo
ZymeworksZYME
-$45.72M-1,242%
Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
-$71.91M-17.7%

Other financials

Income statement

See full
Revenue$20.0M
Operating income-$26.6M+25.0%
Net income-$24.2M+26.2%
EPS (diluted)-$0.45+60.9%

Balance sheet

See full
Cash & equivalents$198.8M-32.5%
Total debt$61.2M+137%
Total equity$341.7M+17.0%
Total assets$419.7M+26.1%

Cash flow

See full
CapEx$93.0K-68.9%
Free cash flow-$39.2M-31.5%

Valuation

See full
Market cap$1.48B
Enterprise value$1.34B
P/S7.9×

Profitability

See full
Operating margin-71.5%
Net margin-65.4%
FCF margin-65.1%

Returns & leverage

See full
Return on equity-38.7%
Debt / equity0.2×+0.1×
Current ratio17.9×+1.8×

Where this comes from

Reported directly by MAZE in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The official record: MAZE’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about MAZE's operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MAZE's operating cash flow?
MAZE (MAZE) reported operating cash flow of -$39.11M in Q1 2026.
How has MAZE's operating cash flow changed year-over-year?
MAZE's operating cash flow decreased by 32.5% year-over-year, from -$29.52M to -$39.11M.
What does operating cash flow mean?
Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.